L

LSL Pharma Group Inc
XTSX:LSL

Watchlist Manager
LSL Pharma Group Inc
XTSX:LSL
Watchlist
Price: 0.35 CAD Market Closed
Market Cap: 42.4m CAD

LSL Pharma Group Inc
Cash from Operating Activities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

LSL Pharma Group Inc
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
L
LSL Pharma Group Inc
XTSX:LSL
Cash from Operating Activities
-CA$1.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Cash from Operating Activities
$1.5B
CAGR 3-Years
N/A
CAGR 5-Years
10%
CAGR 10-Years
-5%
X
Xenon Pharmaceuticals Inc
NASDAQ:XENE
Cash from Operating Activities
-$252m
CAGR 3-Years
-43%
CAGR 5-Years
-75%
CAGR 10-Years
-32%
K
Knight Therapeutics Inc
TSX:GUD
Cash from Operating Activities
CA$35.6m
CAGR 3-Years
-4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Spectral Medical Inc
TSX:EDT
Cash from Operating Activities
-CA$9.1m
CAGR 3-Years
2%
CAGR 5-Years
-115%
CAGR 10-Years
0%
Cipher Pharmaceuticals Inc
TSX:CPH
Cash from Operating Activities
$30m
CAGR 3-Years
26%
CAGR 5-Years
32%
CAGR 10-Years
10%
No Stocks Found

LSL Pharma Group Inc
Glance View

Market Cap
42.4m CAD
Industry
N/A

LSL Pharma Group, Inc. operates as a pharmaceutical company. The company is headquartered in Boucherville, Quebec. The company went IPO on 2011-03-08. The firm specializes in the development, manufacturing, and distribution of natural health products and dietary supplements in solid dosage forms. The firm is also engaged in selling sterile ophthalmic pharmaceutical products.

LSL Intrinsic Value
0.39 CAD
Undervaluation 11%
Intrinsic Value
Price
L

See Also

What is LSL Pharma Group Inc's Cash from Operating Activities?
Cash from Operating Activities
-1.7m CAD

Based on the financial report for Dec 31, 2024, LSL Pharma Group Inc's Cash from Operating Activities amounts to -1.7m CAD.

What is LSL Pharma Group Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 1Y
77%

Over the last year, the Cash from Operating Activities growth was 77%.

Back to Top